folic acid has been researched along with Pancreatic Neoplasms in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.08) | 18.7374 |
| 1990's | 2 (4.08) | 18.2507 |
| 2000's | 16 (32.65) | 29.6817 |
| 2010's | 24 (48.98) | 24.3611 |
| 2020's | 5 (10.20) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, T; Hirata, E; Idogawa, M; Imoto, I; Tange, S; Tokino, T | 1 |
| Chang, H; Fu, H; Gu, Y; Liu, C; Zeng, J; Zou, Y | 1 |
| Mao, QQ; Wei, DH | 1 |
| Abdul Mahdi, S; Al-Musawi, S; Albukhaty, S; Alwahibi, MS; Dewir, YH; Rizwana, H; Soliman, DA; Sulaiman, GM | 1 |
| Cao, X; Chen, T; Fang, X; Fu, Y; Gu, J; Li, H; Li, Y; Liu, X; Shang, M; Wang, T; Xiao, J; Yang, H; Yang, R; Yu, Q; Zhang, J; Zhang, K; Zhang, Q | 1 |
| Anderson, KE; Bamlet, WR; Jansen, RJ; Oberg, AL; Olson, JE; Petersen, GM; Sinha, R; Stolzenberg-Solomon, RZ; Yallew, W | 1 |
| Abdulla, A; Bagust, A; Beale, S; Boland, A; Fleeman, N; Kotas, E; McEntee, J; Palmer, D; Richardson, M; Stainthorpe, A | 1 |
| Chen, Z; Chiorean, EG; Chittiboyina, S; Hocevar, BA; Kamendulis, LM | 1 |
| Cao, X; Chen, X; Dai, Y; He, H; Li, H; Li, K; Liang, J; Pang, L; Xu, X; Zeng, Q; Zhan, Y | 1 |
| Anderson, KE; Fan, H; Hoyt, ML; Marley, AR; Zhang, J | 1 |
| Chen, X; Guan, S; Lan, B; Li, N; Li, W; Luo, J; Tan, J; Wang, X; Xin, Y; Yan, L; Yang, L; Yu, Z; Zeng, C; Zhang, LM | 1 |
| Arteta, B; Benedicto, A; Hernandez-Unzueta, I; Herrero, A; Márquez, J; Olaso, E; Romayor, I; Sanz, E | 1 |
| Deng, S; Fan, G; Luan, Y; Peng, M; Qin, X; Wan, R; Wu, Y; Wu, Z; Xu, L | 1 |
| Wang, J; Xu, Q; Xu, S; Zhang, L; Zhang, N; Zhou, J | 1 |
| An, QZ; Lin, HL; Liu, CX; Wang, QZ | 1 |
| Andrici, J; Cox, MR; Eslick, GD; Tio, M | 1 |
| Cheng, K; Li, H; Qiu, Q; Ruan, G; Tian, J; Tian, Y; Wang, L; Xiao, M; Xue, Y; Yang, H | 1 |
| Kohen, A; Nilaweera, TD; Saeed, M | 1 |
| Egawa, N; Endo, T; Hosono, S; Ishii, H; Ishii, N; Ito, K; Kikuchi, S; Kimura, Y; Kobayashi, Y; Kuruma, S; Lin, Y; Matsuo, K; Matsuyama, M; Mori, M; Nakamura, K; Nakao, H; Nishiyama, T; Nojima, M; Ohkawa, S; Shimada, K; Takahashi, M; Tamakoshi, A; Ueno, M; Wakai, K; Yoneda, M | 1 |
| Jansen, RJ; Weisbeck, A | 1 |
| Bracci, PM; Gong, Z; Holly, EA | 1 |
| Goldbohm, RA; Heinen, MM; Keszei, AP; van den Brandt, PA; Verhage, BA | 1 |
| Church, TR; Dodd, KW; Jiao, L; Meinhold, CL; Oaks, BM; Stolzenberg-Solomon, RZ | 1 |
| de Mejia, EG; Johnson, J | 1 |
| Brand, RE; Greer, JB | 1 |
| Benetou, V; Boeing, H; Boutron-Ruault, MC; Bueno-de-Mesquita, B; Chuang, SC; Clavel-Chapelon, F; Crowe, F; Duell, EJ; Gurrea, AB; Huerta, JM; Jenab, M; Jeurnink, S; Johansen, D; Kaaks, R; Khaw, KT; Larrañaga, N; Manjer, J; Michaud, DS; Midttun, Ø; Molina-Montes, E; Morois, S; Naska, A; Olsen, A; Overvad, K; Palli, D; Panico, S; Peeters, PH; Riboli, E; Rodriguez, L; Romieu, I; Sacerdote, C; Sieri, S; Skeie, G; Slimani, N; Stolzenberg-Solomon, R; Sund, M; Teucher, B; Tjønneland, A; Trichopoulou, A; Tumino, R; Ueland, PM; Vineis, P; Vollset, SE; Wareham, N; Weikert, C; Ye, W | 1 |
| Chang, CW; Ding, H; Erogbogbo, F; Law, WC; Prasad, PN; Roy, I; Swihart, MT; Tien, CA; Yong, KT | 1 |
| Li, Z; Lu, J; Tamanoi, F; Zink, JI | 1 |
| Albanes, D; Anderson, KE; Bao, Y; Bernstein, L; English, DR; Freudenheim, JL; Fuchs, CS; Giles, GG; Giovannucci, E; Goldbohm, RA; Håkansson, N; Horn-Ross, PL; Jacobs, EJ; Kitahara, CM; Marshall, JR; Michaud, DS; Miller, AB; Robien, K; Rohan, TE; Schatzkin, A; Smith-Warner, SA; Spiegelman, D; Stevens, VL; Stolzenberg-Solomon, RZ; van den Brandt, PA; Virtamo, J; Wolk, A; Ziegler, RG | 1 |
| Sanchez, GV; Stolzenberg-Solomon, RZ; Weinstein, SJ | 1 |
| Ali, S; Haq, S; Mohammad, R; Sarkar, FH | 1 |
| Longnecker, DS | 1 |
| Höffken, K; Kliche, KO; Kubsch, K; Masri-Zada, R; Raida, M | 1 |
| Kindler, HL | 1 |
| Büchler, MW; Dunn, JA; Friess, H; Ghaneh, P; Hickey, H; Neoptolemos, JP; Raraty, MG; Stocken, DD | 1 |
| Büchler, MW; Fischer, L; Friess, H; Uhl, W; Z'graggen, K | 1 |
| Risch, HA | 1 |
| Colditz, GA; Fuchs, CS; Giovannucci, EL; Michaud, DS; Rimm, EB; Skinner, HG; Stampfer, MJ; Willett, WC | 1 |
| Eibl, G; Jolly, CI; Narayanan, S; Patil, S | 1 |
| Abbruzzese, JL; Ahmed, M; Bondy, ML; Chou, TH; Evans, DB; Hassan, MM; Jiao, L; Lenzi, R; Li, D; Li, Y; Pisters, PW; Wolff, RA | 1 |
| Kim, YI | 2 |
| Giovannucci, E; Håkansson, N; Larsson, SC; Wolk, A | 1 |
| Giovannucci, E; Larsson, SC; Wolk, A | 1 |
| Büchler, MW; Hoffmann, K; Jäger, D; Märten, A; Schmidt, J | 1 |
| Cochrane, B; Fuchs, C; Giovannucci, E; Ma, J; Manson, JA; Rifai, N; Schernhammer, E; Stampfer, MJ; Thomson, C; Wolpin, B | 1 |
| Albanes, D; Hartman, TJ; Nieto, FJ; Rautalahti, M; Sehlub, J; Stolzenberg-Solomon, RZ; Tangrea, JA; Taylor, PR; Virtamo, J | 1 |
| Panizon, F; Ventura, A | 1 |
| Leeming, RJ; Melikian, V; Paton, A; Portman-Graham, H | 1 |
19 review(s) available for folic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
Folate Intake and Risk of Pancreatic Cancer: A Systematic Review and Updated Meta-Analysis of Epidemiological Studies.
Topics: Folic Acid; Humans; Pancreatic Neoplasms; Risk Factors; Vitamin B Complex | 2021 |
Vitamin B6, vitamin B12 and methionine and risk of pancreatic cancer: a meta-analysis.
Topics: Diet; Folic Acid; Humans; Methionine; Pancreatic Neoplasms; Risk Factors; Vitamin B 12; Vitamin B 6 | 2020 |
Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Fluorouracil; Folic Acid; Humans; Irinotecan; Leucovorin; Pancreatic Neoplasms; Technology Assessment, Biomedical; Topoisomerase I Inhibitors | 2018 |
Folate intake and pancreatic cancer risk: an overall and dose-response meta-analysis.
Topics: Case-Control Studies; Cohort Studies; Diet; Dose-Response Relationship, Drug; Folic Acid; Humans; Pancreatic Neoplasms; Risk | 2013 |
Folate intake and the risk of upper gastrointestinal cancers: a systematic review and meta-analysis.
Topics: Esophageal Neoplasms; Folic Acid; Humans; Pancreatic Neoplasms; PubMed; Risk | 2014 |
Nutrients and the Pancreas: An Epigenetic Perspective.
Topics: Diet; Epigenesis, Genetic; Fatty Acids; Folic Acid; Fruit; Humans; Meat Products; Micronutrients; Nutritional Status; Pancreas; Pancreatic Neoplasms; Red Meat; Risk Factors; Vegetables | 2017 |
Dietary factors and pancreatic cancer: the role of food bioactive compounds.
Topics: Adenocarcinoma; Citrus; Curcumin; Diet; Feeding Behavior; Flavonoids; Folic Acid; Food; Humans; Pancreatic Neoplasms; Risk Factors; United States; Vitamin D | 2011 |
New developments in pancreatic cancer.
Topics: Adenocarcinoma; Adiposity; Alcohol Drinking; Blood Group Antigens; Body Mass Index; CA-19-9 Antigen; Diet; Fanconi Anemia Complementation Group N Protein; Folic Acid; Heredity; Humans; Mutation; Nuclear Proteins; Pancreatic Neoplasms; Prognosis; Risk Factors; Smoking; Tumor Suppressor Proteins; Vitamin D | 2011 |
Folate intake and risk of pancreatic cancer: pooled analysis of prospective cohort studies.
Topics: Cohort Studies; Confounding Factors, Epidemiologic; Feeding Behavior; Female; Folic Acid; Follow-Up Studies; Humans; Male; Multivariate Analysis; Odds Ratio; Pancreatic Neoplasms; Proportional Hazards Models; Prospective Studies; Risk Assessment; Surveys and Questionnaires | 2011 |
Is dietary fat, vitamin D, or folate associated with pancreatic cancer?
Topics: Diet; Dietary Fats; Folic Acid; Humans; Pancreatic Neoplasms; Risk Factors; Vitamin D | 2012 |
The complexities of epidemiology and prevention of gastrointestinal cancers.
Topics: Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Diabetes Complications; Folic Acid; Gastrointestinal Neoplasms; Humans; Hypoglycemic Agents; Inflammatory Bowel Diseases; Metformin; Obesity; Pancreatic Neoplasms; Smoking | 2012 |
Abnormal methyl metabolism in pancreatic toxicity and diabetes.
Topics: Animals; Cell Differentiation; Diabetes Mellitus; DNA Methylation; Folic Acid; Pancreas; Pancreatic Neoplasms; Pancreatitis; Rats | 2002 |
Pemetrexed in pancreatic cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Folic Acid; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; Pancreatic Neoplasms; Pemetrexed; Thymidylate Synthase; Vitamin B 12 | 2002 |
[Adjuvant and additive therapy for cancer of the pancreas].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Controlled Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Folic Acid; Gemcitabine; Hematinics; Humans; Leucovorin; Male; Mitoxantrone; Multicenter Studies as Topic; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Pancreatic Neoplasms; Quality of Life; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Surveys and Questionnaires; Time Factors | 2003 |
Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity.
Topics: Animals; Anticarcinogenic Agents; Bicarbonates; Carotenoids; Diabetes Complications; Duodenal Ulcer; Feeding Behavior; Female; Folic Acid; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Lycopene; Male; Nitroso Compounds; Pancreatic Neoplasms; Secretin | 2003 |
Folate and methylenetetrahydrofolate reductase polymorphisms: new nutritional and genetic risk factors for pancreatic cancer?
Topics: Amino Acid Substitution; Diet; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Pancreatic Neoplasms; Polymorphism, Single Nucleotide; Risk Factors | 2005 |
Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Case-Control Studies; Esophageal Neoplasms; Folic Acid; Gastrointestinal Neoplasms; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Pancreatic Neoplasms; Polymorphism, Genetic; Risk Factors; Stomach Neoplasms | 2006 |
Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects.
Topics: Adolescent; Adult; Alcohol Drinking; Animals; beta Carotene; Breast Neoplasms; Case-Control Studies; Female; Folic Acid; Follow-Up Studies; Hematinics; Humans; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasms; Odds Ratio; Pancreatic Neoplasms; Postmenopause; Premenopause; Prospective Studies; Randomized Controlled Trials as Topic; Rats; Risk; Risk Factors; Smoking; Time Factors; Vitamins | 1999 |
[Juvenile endocrine hypoglycemia].
Topics: Adenoma; Child, Preschool; Diazoxide; Folic Acid; Fructose-1,6-Diphosphatase Deficiency; Gluconeogenesis; Growth Hormone; Humans; Hyperinsulinism; Hyperplasia; Hypoglycemia; Islets of Langerhans; Ketosis; Pancreatic Neoplasms; Prognosis | 1979 |
4 trial(s) available for folic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
The role of the folate pathway in pancreatic cancer risk.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Erythrocytes; Female; Folic Acid; Humans; Male; Middle Aged; Neoplasm Proteins; Pancreatic Neoplasms; Polymorphism, Single Nucleotide; Risk Factors; United States | 2018 |
Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Topics: Adenocarcinoma; Aged; Cohort Studies; Eating; Female; Folic Acid; Food, Fortified; Humans; Male; Middle Aged; Pancreatic Neoplasms; Proportional Hazards Models; Sex Factors; Surveys and Questionnaires | 2010 |
Chronomodulated chemotherapy in metastatic gastrointestinal cancer combining 5-FU and sodium folinate with oxaliplatin, irinotecan or gemcitabine: the Jena experience in 79 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Camptothecin; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Folic Acid; Gastrointestinal Neoplasms; Gemcitabine; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Stomach Neoplasms | 2002 |
Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytokines; Fluorouracil; Folic Acid; Granzymes; Humans; Immunophenotyping; Interferon-alpha; Killer Cells, Natural; Leukocytes; Pancreatic Neoplasms; Prospective Studies | 2007 |
26 other study(ies) available for folic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway.
Topics: Cell Line, Tumor; Demethylation; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Mechanistic Target of Rapamycin Complex 1; Neoplastic Processes; Pancreatic Neoplasms; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-myc | 2023 |
Investigation of Dextran-Coated Superparamagnetic Nanoparticles for Targeted Vinblastine Controlled Release, Delivery, Apoptosis Induction, and Gene Expression in Pancreatic Cancer Cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Dextrans; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Magnetite Nanoparticles; Neoplasm Proteins; Pancreatic Neoplasms; Vinblastine | 2020 |
The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation.
Topics: Aminohydrolases; Animals; B7-H1 Antigen; Carcinogenesis; Cell Line, Tumor; Embryo, Mammalian; Fibroblasts; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Methylenetetrahydrofolate Dehydrogenase (NADP); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Multifunctional Enzymes; Pancreatic Neoplasms; Primary Cell Culture; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Signal Transduction; T-Lymphocytes, Cytotoxic; Tumor Burden; Tumor Escape; Uridine Diphosphate N-Acetylglucosamine; Xenograft Model Antitumor Assays | 2021 |
Association between Alcohol Consumption, Folate Intake, and Risk of Pancreatic Cancer: A Case-Control Study.
Topics: Aged; Alcohol Drinking; Body Mass Index; Case-Control Studies; Diet; Dietary Supplements; Female; Folic Acid; Humans; Male; Middle Aged; Nutritional Status; Pancreatic Neoplasms; Risk Factors | 2017 |
In vivo near infrared fluorescence imaging and dynamic quantification of pancreatic metastatic tumors using folic acid conjugated biodegradable mesoporous silica nanoparticles.
Topics: Animals; Fluorescence; Folic Acid; Humans; Mice; Nanoparticles; Optical Imaging; Pancreatic Neoplasms; Silicon Dioxide; Spectroscopy, Near-Infrared; Tumor Cells, Cultured | 2018 |
Intake of methyl-related nutrients and risk of pancreatic cancer in a population-based case-control study in Minnesota.
Topics: Adult; Aged; Case-Control Studies; Diet; Dietary Supplements; DNA Methylation; Female; Folic Acid; Humans; Male; Methionine; Middle Aged; Minnesota; Odds Ratio; Pancreatic Neoplasms; Risk Factors; Vitamin B 12; Vitamin B 6 | 2018 |
Spectroscopic investigation of a hyperbranched cationic amylopectin derivative as a multi-guest molecular host for targeted delivery of a photosensitizer to pancreatic cancer cells.
Topics: Amylopectin; Cations; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Folic Acid; Humans; Magnetic Resonance Spectroscopy; Pancreatic Neoplasms; Photosensitizing Agents; Protoporphyrins; Spectrometry, Fluorescence; Spectrometry, X-Ray Emission; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 2018 |
Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Ascorbic Acid; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Folic Acid; Gemcitabine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mice, Inbred C57BL; Neoplasms, Experimental; Paclitaxel; Pancreatic Neoplasms; Pantothenic Acid; Plant Extracts; Solutions; Vitamin B 12; Vitamin B 6; Zinc Sulfate | 2019 |
The target therapeutic effect of functionalized graphene oxide nanoparticles graphene oxide-polyethylene glycol-folic acid-1-pyrenemethylamine hydrochloride-mediated RNA interference of HIF-1α gene in human pancreatic cancer cells.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Fluorodeoxyglucose F18; Folic Acid; Gene Knockdown Techniques; Genetic Therapy; Glucose Transporter Type 1; Graphite; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Methylamines; Mice, Nude; Molecular Targeted Therapy; Nanoparticles; Neoplasms, Experimental; Pancreatic Neoplasms; Polyethylene Glycols; Pyrenes; RNA Interference; RNA, Messenger; Transfection | 2019 |
Preparation and characterization of folate-chitosan-gemcitabine core-shell nanoparticles for potential tumor-targeted drug delivery.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Deoxycytidine; Diffusion; Folic Acid; Gemcitabine; Humans; Materials Testing; Nanocapsules; Pancreatic Neoplasms; Porosity; Treatment Outcome | 2013 |
Interaction of Serum microRNAs and Serum Folate With the Susceptibility to Pancreatic Cancer.
Topics: Aged; Biomarkers, Tumor; Case-Control Studies; Cell Line, Tumor; China; Female; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Middle Aged; Pancreatic Neoplasms; Predictive Value of Tests; Prognosis; Radioimmunoassay; Real-Time Polymerase Chain Reaction; Risk Factors; Smoking | 2015 |
Targeting the de novo biosynthesis of thymidylate for the development of a PET probe for pancreatic cancer imaging.
Topics: Carbon Isotopes; Folic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Pancreatic Neoplasms; Positron-Emission Tomography; Radioactive Tracers; Radiography; Thymidine Monophosphate; Thymidylate Synthase; Uridine Monophosphate | 2015 |
Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Alcohol Drinking; Case-Control Studies; Female; Ferredoxin-NADP Reductase; Folic Acid; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Pancreatic Neoplasms; Polymorphism, Single Nucleotide; Risk Factors; Smoking | 2016 |
Intake of folate, vitamins B6, B12 and methionine and risk of pancreatic cancer in a large population-based case-control study.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Case-Control Studies; Diet Surveys; Eating; Female; Folic Acid; Humans; Male; Methionine; Micronutrients; Middle Aged; Pancreatic Neoplasms; Population; Risk Factors; Vitamin B 12; Vitamin B 6; Young Adult | 2009 |
Dietary folate and folate vitamers and the risk of pancreatic cancer in the Netherlands cohort study.
Topics: Aged; Cohort Studies; Diet; Dietary Supplements; Female; Folic Acid; Humans; Incidence; Male; Middle Aged; Netherlands; Pancreatic Neoplasms; Risk Factors; Surveys and Questionnaires; Vitamin B Complex | 2009 |
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Topics: Adult; Aged; Alcohol Drinking; Body Mass Index; Case-Control Studies; Cotinine; Diabetes Complications; DNA-Binding Proteins; Europe; Female; Flavin Mononucleotide; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Logistic Models; Male; Methionine; Middle Aged; Odds Ratio; Pancreatic Neoplasms; Prospective Studies; Pyridoxal Phosphate; Riboflavin; Risk Factors; Sex Factors; Smoking; Transcription Factors; Vitamin B 12; Vitamin B Complex | 2011 |
Bioconjugation of luminescent silicon quantum dots for selective uptake by cancer cells.
Topics: Cell Line, Tumor; Coated Materials, Biocompatible; Folic Acid; Humans; Luminescence; Lysine; Materials Testing; Molecular Imaging; Molecular Structure; Pancreatic Neoplasms; Particle Size; Quantum Dots; Silicon; Stereoisomerism; Surface Properties; Transferrin | 2011 |
In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Drug Delivery Systems; Folic Acid; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Pancreatic Neoplasms; Silicates; Transplantation, Heterologous | 2012 |
[Operative management in the treatment of pancreatic cancer].
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Therapy, Combination; Fluorouracil; Folic Acid; Hematinics; Humans; Multicenter Studies as Topic; Neoplasm Metastasis; Pancreatic Neoplasms; Pancreaticoduodenectomy; Prospective Studies; Time Factors | 2003 |
A prospective study of folate intake and the risk of pancreatic cancer in men and women.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Cohort Studies; Dietary Supplements; Drug Interactions; Feeding Behavior; Female; Folic Acid; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Pancreatic Neoplasms; Prospective Studies; Risk Assessment; Risk Factors; Sex Factors; Smoking; United States | 2004 |
Evaluation of antimitotic activity of Rotula aquatica (Lour): a traditional herb used in treatment of cancer.
Topics: Allium; Antimetabolites, Antineoplastic; Boraginaceae; Cell Division; Chromatography, High Pressure Liquid; Folic Acid; Mass Spectrometry; Methotrexate; Mitotic Index; Pancreatic Neoplasms; Phytotherapy; Plant Extracts; Plant Roots; Steroids; Tannins | 2004 |
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Alcohol Drinking; Case-Control Studies; Female; Folic Acid; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Pancreatic Neoplasms; Polymorphism, Genetic; Risk Factors; Smoking | 2005 |
Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men.
Topics: Adult; Aged; Alcohol Drinking; Anticarcinogenic Agents; Dietary Supplements; Feeding Behavior; Female; Folic Acid; Fruit; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pancreatic Neoplasms; Proportional Hazards Models; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires; Sweden; Treatment Outcome; Vegetables | 2006 |
Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts.
Topics: Adult; Case-Control Studies; Cohort Studies; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Pancreatic Neoplasms; Risk Factors; Vitamin B 12; Vitamin B 6 | 2007 |
Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers.
Topics: Aged; Biomarkers, Tumor; Case-Control Studies; Folic Acid; Fruit; Homocysteine; Humans; Logistic Models; Male; Methylation; Middle Aged; Odds Ratio; Pancreatic Neoplasms; Pyridoxine; Risk; Smoking; Vegetables; Vitamin B 12 | 1999 |
Site of reduction and methylation of folic acid in man.
Topics: Administration, Oral; Biological Assay; Biotransformation; Catheterization; Chromatography; Colonic Neoplasms; Enterococcus faecalis; Folic Acid; Hepatic Veins; Humans; Lactobacillus; Liver; Liver Cirrhosis; Methylation; Oxidation-Reduction; Pancreatic Neoplasms; Portal Vein; Tetrazolium Salts; Time Factors | 1971 |